Multi-agent chemotherapy for early breast cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Multi-agent Chemotherapy for Early Breast Cancer: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431058/all/Chest_physiotherapy_for_acute_bronchiolitis_in_paediatric_patients_between_0_and_24_months_old_Edited__no_change_to_conclusions___comment_added_to_review.
Multi-agent chemotherapy for early breast cancer: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431058/all/Chest_physiotherapy_for_acute_bronchiolitis_in_paediatric_patients_between_0_and_24_months_old_Edited__no_change_to_conclusions___comment_added_to_review. Accessed July 16, 2025.
Multi-agent chemotherapy for early breast cancer: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431058/all/Chest_physiotherapy_for_acute_bronchiolitis_in_paediatric_patients_between_0_and_24_months_old_Edited__no_change_to_conclusions___comment_added_to_review
Multi-agent Chemotherapy for Early Breast Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431058/all/Chest_physiotherapy_for_acute_bronchiolitis_in_paediatric_patients_between_0_and_24_months_old_Edited__no_change_to_conclusions___comment_added_to_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Multi-agent chemotherapy for early breast cancer: Cochrane systematic review
ID - 431058
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431058/all/Chest_physiotherapy_for_acute_bronchiolitis_in_paediatric_patients_between_0_and_24_months_old_Edited__no_change_to_conclusions___comment_added_to_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -